These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 17295682)
21. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers. Senden NH; Timmer ED; de Bruïne A; Wagenaar SS; Van de Velde HJ; Roebroek AJ; Van de Ven WJ; Broers JL; Ramaekers FC J Pathol; 1997 May; 182(1):13-21. PubMed ID: 9227337 [TBL] [Abstract][Full Text] [Related]
22. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer. Nisman B; Heching N; Biran H; Barak V; Peretz T Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245 [TBL] [Abstract][Full Text] [Related]
23. Chromogranin A, neuron-specific enolase and synaptophysin as neuroendocrine cell markers in the diagnosis of tumours of the gastro-entero-pancreatic system. Schürmann G; Betzler M; Buhr HJ Eur J Surg Oncol; 1990 Aug; 16(4):298-303. PubMed ID: 2116326 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers. Kulshrestha R; Vijayan VK Indian J Chest Dis Allied Sci; 2009; 51(1):21-5. PubMed ID: 19317359 [TBL] [Abstract][Full Text] [Related]
25. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716 [TBL] [Abstract][Full Text] [Related]
26. [Role of the cut-off value of serum neuron-specific enolase in differentiating small cell lung cancer from non-small cell lung cancer]. Wei T; Luo RC; Zuo Q; Zhang JY; Miao JX; Lu HF Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):858-9. PubMed ID: 16793621 [TBL] [Abstract][Full Text] [Related]
27. [Study on the specific expressions of p53, bcl-2 and c-myc in non-small cell lung cancer with neuroendocrine differentiation]. Zhang W; Lin Y; Xiong Y; Liu M; Chen F Zhongguo Fei Ai Za Zhi; 2002 Feb; 5(1):21-4. PubMed ID: 21315022 [TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine differentiation in non-small cell lung carcinomas. Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067 [TBL] [Abstract][Full Text] [Related]
29. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related]
30. Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer. Ather MH; Abbas F; Faruqui N; Israr M; Pervez S BMC Urol; 2008 Dec; 8():21. PubMed ID: 19115997 [TBL] [Abstract][Full Text] [Related]
31. Focal neuroendocrine differentiation in non-small cell carcinoma is not predicted by pre-operative routine investigation. Wallace WA Eur J Surg Oncol; 2002 Feb; 28(1):63-6. PubMed ID: 11869016 [TBL] [Abstract][Full Text] [Related]
32. [The value of neuroendocrine markers for response to therapy and survival in patients with advanced non-small cell lung cancer]. Petrović M; Ilić N; Baskić D Srp Arh Celok Lek; 2010; 138(1-2):37-42. PubMed ID: 20422910 [TBL] [Abstract][Full Text] [Related]
33. Cut-off levels of NSE to differentiate SCLC from NSCLC. Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631 [TBL] [Abstract][Full Text] [Related]
34. Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer. Petrovic M; Tomic I; Plavec G; Ilic S; Ilic N; Baskic D J BUON; 2008; 13(1):93-6. PubMed ID: 18404793 [TBL] [Abstract][Full Text] [Related]
35. Expression of chromogranin A mRNA in small cell carcinoma of the lung. Hamid Q; Corrin B; Sheppard MN; Huttner WB; Polak JM J Pathol; 1991 Apr; 163(4):293-7. PubMed ID: 1851827 [TBL] [Abstract][Full Text] [Related]
36. Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells. Kashiwagi K; Ishii J; Sakaeda M; Arimasu Y; Shimoyamada H; Sato H; Miyata C; Kamma H; Aoki I; Yazawa T Pathol Int; 2012 Apr; 62(4):232-45. PubMed ID: 22449227 [TBL] [Abstract][Full Text] [Related]
37. Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. Fernandes AP; Capitanio A; Selenius M; Brodin O; Rundlöf AK; Björnstedt M Histopathology; 2009 Sep; 55(3):313-20. PubMed ID: 19723146 [TBL] [Abstract][Full Text] [Related]
38. Activity and tissue localization of cathepsin G in non small cell lung cancer. Maksimowicz T; Chyczewska E; Chyczewski L; Nikliński J; Ostrowska H; Szyszko J; Furman M Rocz Akad Med Bialymst; 1997; 42 Suppl 1():199-216. PubMed ID: 9337538 [TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine phenotype of non-small cell lung carcinoma: immunohistological evaluation and biochemical study. Slodkowska J; Zych J; Szturmowicz M; Demkow U; Rowinska-Zakrzewska E; Roszkowski-Sliz K Int J Biol Markers; 2005; 20(4):217-26. PubMed ID: 16398403 [TBL] [Abstract][Full Text] [Related]
40. [Combined small-cell carcinoma/adenocarcinoma of prostate: report of two cases]. Sakuma T; Yoshida T; Ohashi H; Nishimura K; Kawano K Hinyokika Kiyo; 2007 Jul; 53(7):489-92. PubMed ID: 17702184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]